2,250
-0.44%
Close of 9 Nov 2026, in IDR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Tempo Scan Pacific Tbk PT
Its shares trade on IDX under the ticker TSPC.JK. It has been listed since 17 June 1994. In the fiscal year to 31 December 2025, it reported revenue of IDR 14.01trn and net income of IDR 1.41trn. At that date it held total assets of IDR 13.09trn and shareholders' equity of IDR 9.19trn.
PT Tempo Scan Pacific Tbk engages in the pharmaceutical business. The company is headquartered in Jakarta, Dki Jakarta. The Company’s segments include Pharmaceuticals, Consumer Products and Cosmetics, and Distribution Services. The Pharmaceuticals segment conducts marketing of consumer health products consisting of over the counter; vitamin, mineral and supplement (VMS) and beverage products; nutritional products and herbal products; and prescription medicine products. The Consumer Products and Cosmetics segment markets and distributes own branded products as well as licensed cosmetics products. The Distribution Services segment distributes products to customers. The segment serves customers from various sales branches throughout Indonesia, covering pharma, modern trade, and general trade channels. The company also markets and distributes its products overseas through its international business units. Its business network covers about 220 locations that consist of 47 branches.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 17 Jun 1994
- Employees
- 4,525
- Website
- temposcangroup.com ↗
Leadership
Pay as last reported
- Mr. Handojo Selamet MuljadiPresident Commissioner, since 1995
- Mr. I. Made Dharma WijayaPresident Director
- Ms. Liza PrasodjoVice President Director
- Ms. Diana WirawanVice President Director
- Ms. Rorita LimDirector
- Ms. Linda LukitasariDirector
- Mr. Benny SetiawanDirector
- Ms. Hartaty SusantoDirector
- Mr. Prayoga WahyudiantoDirector
- Ms. Shania ..Director, Corporate Secretary
- Ms. Dewi Murni SukaharCommissioner, since 1997
- Ms. Nona KustantinahIndependent Commissioner
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Pharmaceuticals segment markets over-the-counter and prescription medicines in Indonesia.
- Consumer Products and Cosmetics segment distributes own branded and licensed cosmetics.
- Distribution Services segment covers 220 locations across Indonesia with 47 branches.
Weaknesses
- Pharmaceuticals segment focuses on OTC and VMS products with limited prescription medicine expansion.
- Consumer Products and Cosmetics segment relies on licensed cosmetics without own R&D.
- Distribution Services segment serves only Indonesia with no international expansion.
Opportunities
- Pharmaceuticals segment can expand into prescription medicine products in Indonesia.
- Consumer Products and Cosmetics segment can develop own R&D for branded cosmetics.
- Distribution Services segment can expand internationally through overseas business units.
Threats
- Pharmaceuticals segment faces competition from imported prescription medicines in Indonesia.
- Consumer Products and Cosmetics segment encounters competition from global cosmetics brands.
- Distribution Services segment experiences pressure from modern trade channel competition in Indonesia.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.